| Year of Transplant | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Transplants | 2,188 | 2,199 | 2,202 | 2,155 | 2,057 | 2,015 | 2,125 | 2,193 | 2,209 | 2,163 |
| With Immunosuppression Info | 2,138 | 2,148 | 2,152 | 2,119 | 2,024 | 1,974 | 2,056 | 2,120 | 2,152 | 2,110 |
| Induction Drugs | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| ALG | ||||||||||
| Atgam/NRATG/NRATS | 12.0% | 9.4% | 7.7% | 7.0% | 7.9% | 7.2% | 6.9% | 4.7% | 4.2% | 6.5% |
| OKT3 | 11.1% | 8.7% | 8.6% | 5.4% | 4.6% | 3.6% | 3.2% | 3.1% | 3.2% | 1.4% |
| Thymoglobulin | 2.5% | 6.9% | 10.7% | 16.2% | 12.9% | 15.7% | 14.7% | 18.2% | 19.1% | 18.1% |
| Zenapax | 7.2% | 8.8% | 13.4% | 11.4% | 14.6% | 15.7% | 15.6% | 14.5% | 12.8% | 11.1% |
| Simulect | 2.5% | 5.1% | 5.2% | 7.0% | 9.3% | 10.2% | 13.6% | 15.0% | 14.3% | 14.0% |
| Campath | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.9% | 0.7% | 1.7% | 2.6% | 3.4% |
| No Induction Drugs Recorded | 65.7% | 62.8% | 56.4% | 55.1% | 52.9% | 52.9% | 47.8% | 45.2% | 46.0% | 47.7% |